Literature DB >> 27469384

Ciprofloxacin and statin interaction: a cautionary tale of rhabdomyolysis.

Fraser Charles Goldie1, Amy Brogan1, James Graham Boyle1.   

Abstract

A 62-year-old woman presented to hospital, on general practitioner (GP) advice, with a 15-day history of slowly progressing muscle weakness. Results showed newly deranged liver function and creatine kinase (CK) of >24 000. Prior medical history includes previous myocardial infarction and recurrent urinary tract infection. 4 days prior to symptom onset, the patient developed typical urinary tract infection symptoms, treated with ciprofloxacin. The patient had been taking simvastatin (40 mg nocte) for 13 years and had never previously taken ciprofloxacin. Initial management included intravenous crystalloid fluids and discontinuation of simvastatin. CK level fell, liver function slowly improved and renal function remained stable. Muscle weakness improved and the patient became independently able to perform activities of daily living. While the interactions between statins and other antibiotics are well documented, the interaction between statins and ciprofloxacin is less so. The consequences of this interaction can have potentially serious outcomes. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27469384      PMCID: PMC4986139          DOI: 10.1136/bcr-2016-216048

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Statins for all by the age of 50 years?

Authors:  Shah Ebrahim; Juan P Casas
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321

Review 2.  Role of P-glycoprotein in statin drug interactions.

Authors:  Carol W Holtzman; Barbara S Wiggins; Sarah A Spinler
Journal:  Pharmacotherapy       Date:  2006-11       Impact factor: 4.705

Review 3.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 4.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Statin-induced rhabdomyolysis: a comprehensive review of case reports.

Authors:  Polyana Mendes; Priscila Games Robles; Sunita Mathur
Journal:  Physiother Can       Date:  2014       Impact factor: 1.037

6.  Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.

Authors:  Amit M Patel; Salimah Shariff; David G Bailey; David N Juurlink; Sonja Gandhi; Muhammad Mamdani; Tara Gomes; Jamie Fleet; Y Joseph Hwang; Amit X Garg
Journal:  Ann Intern Med       Date:  2013-06-18       Impact factor: 25.391

7.  ATP-dependent transport of statins by human and rat MRP2/Mrp2.

Authors:  Lucy C J Ellis; Gabrielle M Hawksworth; Richard J Weaver
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-02       Impact factor: 4.219

8.  Is Ciprofloxacin a Substrate of P-glycoprotein?

Authors:  Miki Susanto Park; Hideaki Okochi; Leslie Z Benet
Journal:  Arch Drug Inf       Date:  2011-03

9.  Severe rhabdomyolysis associated with simvastatin and role of ciprofloxacin and amlodipine coadministration.

Authors:  Nicolas De Schryver; Xavier Wittebole; Peter Van den Bergh; Vincent Haufroid; Eric Goffin; Philippe Hantson
Journal:  Case Rep Nephrol       Date:  2015-03-26

Review 10.  Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review.

Authors:  William J Canestaro; Melissa A Austin; Kenneth E Thummel
Journal:  Genet Med       Date:  2014-05-08       Impact factor: 8.822

View more
  4 in total

Review 1.  Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions.

Authors:  Leigh Anne Hylton Gravatt; Rachel W Flurie; Estela Lajthia; Dave L Dixon
Journal:  Curr Atheroscler Rep       Date:  2017-10-09       Impact factor: 5.113

2.  Sepsis Mortality in Critical Care and Prior Statin Therapy: A Retrospective Cohort Study in Central Argentina.

Authors:  Liberth Incahuanaco Paricahua; Alexis Fabian Oleynick Goncalves; Sandaly Oliveira da Silva Pacheco; Fabio Juliano Pacheco
Journal:  J Clin Diagn Res       Date:  2017-06-01

3.  When Should Statins Be Stopped?

Authors:  Mário Bibi; Ana Ferro; Filipa Guimarães; Paulo Coelho; Inês Chora
Journal:  Eur J Case Rep Intern Med       Date:  2021-06-15

4.  Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Authors:  Chengwen Teng; Courtney Baus; James P Wilson; Christopher R Frei
Journal:  Int J Med Sci       Date:  2019-10-15       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.